Literature DB >> 15828937

Effect of sharp debridement using curette on recalcitrant nonhealing venous leg ulcers: a concurrently controlled, prospective cohort study.

Dean Williams1, Stuart Enoch, David Miller, Karen Harris, Patricia Price, Keith G Harding.   

Abstract

The objective of this study was to evaluate the effect of sharp debridement on the progression of recalcitrant chronic venous leg ulcers (CVLU) and to assess the feasibility of performing this procedure in an outpatient setting. We performed a prospective study of 55 CVLU (53 patients) over a 12-month period. The study group, which underwent debridement, contained 28 CVLU whose wound beds had slough, nonviable tissue, and no granulation tissue. The control group was 27 CVLU with minimal (15-20%) granulation tissue, but no slough or nonviable tissue. Treatments were otherwise similar. Age, body mass index, mean ulcer surface area (MSA) and mean ulcer duration were comparable in both groups. Ulcer measurements were taken at 4 weeks before debridement, at the time of debridement, and 4 and 20 weeks post-debridement. There was no change in the MSA from 4 weeks before to the time of debridement in either group. At 4 weeks post-debridement, the study ulcers showed a 6 cm(2) reduction in the MSA vs. a 1 cm(2) reduction in controls (P = 0.02). By week 20 post-debridement, the study ulcers achieved a 7.4 cm(2) reduction in the MSA vs. an increase of 1.3 cm(2) in controls (P = 0.008). Between weeks 8 and 20 post-debridement, 16% of study ulcers vs. 4.3% of control ulcers achieved complete healing. Infection rates and antimicrobial usage were similar. We conclude that sharp debridement is effective in stimulating healing of recalcitrant CVLU. It is safe, well tolerated, and can be performed in an outpatient setting.

Entities:  

Mesh:

Year:  2005        PMID: 15828937     DOI: 10.1111/j.1067-1927.2005.130203.x

Source DB:  PubMed          Journal:  Wound Repair Regen        ISSN: 1067-1927            Impact factor:   3.617


  12 in total

Review 1.  Wound chronicity and fibroblast senescence--implications for treatment.

Authors:  Keith G Harding; Keith Moore; Tania J Phillips
Journal:  Int Wound J       Date:  2005-12       Impact factor: 3.315

Review 2.  Venous and arterial leg ulcers.

Authors:  Joseph E Grey; Keith G Harding; Stuart Enoch
Journal:  BMJ       Date:  2006-02-11

Review 3.  Care of chronic wounds in palliative care and end-of-life patients.

Authors:  Christine A Chrisman
Journal:  Int Wound J       Date:  2010-05-28       Impact factor: 3.315

Review 4.  National Athletic Trainers' Association Position Statement: Management of Acute Skin Trauma.

Authors:  Joel W Beam; Bernadette Buckley; William R Holcomb; Mario Ciocca
Journal:  J Athl Train       Date:  2017-01-16       Impact factor: 2.860

Review 5.  Debridement for venous leg ulcers.

Authors:  Georgina Gethin; Seamus Cowman; Dinanda N Kolbach
Journal:  Cochrane Database Syst Rev       Date:  2015-09-14

Review 6.  Minimising wound-related pain at dressing change: evidence-informed practice.

Authors:  Kevin Y Woo; Keith Harding; Patricia Price; Gary Sibbald
Journal:  Int Wound J       Date:  2008-06       Impact factor: 3.315

7.  Molecular markers in patients with chronic wounds to guide surgical debridement.

Authors:  Harold Brem; Olivera Stojadinovic; Robert F Diegelmann; Hyacinth Entero; Brian Lee; Irena Pastar; Michael Golinko; Harvey Rosenberg; Marjana Tomic-Canic
Journal:  Mol Med       Date:  2007 Jan-Feb       Impact factor: 6.354

8.  The effect of 22.5 kHz low-frequency contact ultrasound debridement (LFCUD) on lower extremity wound healing for a vascular surgery population: A randomised controlled trial.

Authors:  Christine Anne Murphy; Pamela Houghton; Tim Brandys; Gregory Rose; Dianne Bryant
Journal:  Int Wound J       Date:  2018-01-15       Impact factor: 3.315

Review 9.  Infection in Venous Leg Ulcers: Considerations for Optimal Management in the Elderly.

Authors:  Douglas J Pugliese
Journal:  Drugs Aging       Date:  2016-02       Impact factor: 3.923

10.  The Debrisoft(®) Monofilament Debridement Pad for Use in Acute or Chronic Wounds: A NICE Medical Technology Guidance.

Authors:  Catherine Meads; Eleonora Lovato; Louise Longworth
Journal:  Appl Health Econ Health Policy       Date:  2015-12       Impact factor: 2.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.